Clinical Trials Directory

Trials / Completed

CompletedNCT04764760

Biomechanically Compatible,Minimally Invasive Technique for Recurrence Free Groin Hernia Repair

Former Chairman Department of Surgery St.Joseph Mercy Oakland Pontiac Former Clinical Associate Professor Surgery Wayne State University,Detroit

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
486 (actual)
Sponsor
St. Joseph Mercy Oakland Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

"A bio-mechanically compatible, minimally invasive technique for recurrence-free groin hernia repair by implantation of Tensiflex mesh prosthesis for the enhancement of the tissue tensile strength of the fascia transversalis."

Detailed description

Hernia recurrences post-repair remain a confounding problem. The prospective study described herein tested Cooper's paradigm, which holds that abdominal pressure exceeding abdominal wall resistance causes hernia, by incorporating the Tensiflex mesh prosthesis which is a modified version of mesh prosthesis of Stoppa technique in the surgical treatment of patients with hernia. The study was 2-phased: the first phase involved the pre-peritoneal implantation of a bi-layered mesh for anatomical replacement of the damaged fascia. The second phase involved the implantation of the bi-layered Tensiflex mesh prosthesis for definitive and seamless augmentation of tensile strength in the myopectineal orifice of Fruchaud. Eighty-three percent of our patients consumed analgesics for 3 days (3% reported no pain on day 3); however, by day 5, 86% reported pain intensity scores lower than 5. The median number of lost workdays was 7. Most importantly, the primary endpoint of 100% recurrence-free outcomes was met, as were the secondary endpoints (minimal pain, morbidity, and loss of workdays).

Conditions

Interventions

TypeNameDescription
DEVICEWing shaped Tensiflex prosthesisCurative inguinal hernia repair techniqque

Timeline

Start date
1987-01-01
Primary completion
2001-01-01
Completion
2001-02-01
First posted
2021-02-21
Last updated
2021-02-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04764760. Inclusion in this directory is not an endorsement.